Join to View Full Profile
1365C Clifton Rd NEAtlanta, GA 30322
Phone+1 404-686-5500
Fax+1 404-778-3002
Dr. Pillai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2010 - 2013- Emory University School of MedicineResidency, Internal Medicine, 2007 - 2010
University of Texas Southwestern Medical SchoolClass of 2007
Certifications & Licensure
GA State Medical License 2013 - 2025
Clinical Trials
- An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026) Start of enrollment: 2014 Mar 27
- Study of Glembatumumab Vedotin in gpNMB-Expressing, Advanced or Metastatic SCC of the Lung Start of enrollment: 2016 Apr 10
- Nivolumab in Treating Patients With Advanced Metastatic Non-small Cell Lung Cancer Start of enrollment: 2017 Jul 21
Publications & Presentations
PubMed
- 2 citationsCharacterisation of clinical response and transcriptional profiling of proliferating CD8 T cells in the blood of cancer patients after PD-1 monotherapy or combination ...Rebecca C Obeng, Tahseen H Nasti, Kylee Martens, Peng Li, Annapaola Mariniello
BMJ Oncology. 2024-01-01 - 7 citationsEfficacy and Safety of Glembatumumab Vedotin in Patients With Advanced or Metastatic Squamous Cell Carcinoma of the Lung (PrECOG 0504).Saad A. Khan, Z. Sun, Suzanne E. Dahlberg, Jyoti Malhotra, Roger Keresztes
JTO Clinical and Research Reports. 2021-05-01 - 12 citationsDaratumumab Plus Atezolizumab in Previously Treated Advanced or Metastatic NSCLC: Brief Report on a Randomized, Open-Label, Phase 1b/2 Study (LUC2001 JNJ-54767414)Rathi N. Pillai, Suresh S. Ramalingam, Meena Thayu, Patricia Lorenzini, Diana A. Alvarez Arias
JTO Clinical and Research Reports. 2021-02-01
Journal Articles
- Concurrent Chemoradiotherapy with Weekly Versus Triweekly Cisplatin in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Comparative AnalysisRathi Pillai, Fadlo R Khuri, Nabil F Saba, Conor Steuer, Suchita Pakkala, Kristin Higgins, Jonathan J Beitler, Suresh S Ramalingam, Brandon Twardy, Kelly Schrapp, Taof..., Head & Neck
- Targeted Sequencing and Intracranial Outcomes of Patients with Lung Adenocarcinoma Brain Metastases Treated with RadiotherapyGabriel L Sica, Matthew J Ferris, Walter J Curran, Shannon Kahn, Suresh S Ramalingam, Pretesh R Patel, Rathi N Pillai, Robert H Press, Jim Zhong, Conor E Steuer, Taofe..., Cancer
Press Mentions
OncLive® Presents State of the Science Summit™ on Non-Small Cell Lung CancerJune 25th, 2019
T Cell Revival Correlates with Lung Cancer Response to PD-1 ImmunotherapyApril 24th, 2017
Cancer Immunotherapy: Revived T Cells Still Need FuelMarch 9th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
